Market Place
Sourcing Support
New BIMZELX® Data at ACR 2024 on Psoriatic Arthritis Treatment
14 Nov 2024 //
PR NEWSWIRE
UCB & Biogen’s dapirolizumab pegol paves path for lupus treatment
13 Nov 2024 //
EXPRESSPHARMA
UCB`s tau drug flunks Alzheimer`s trial days after Roche`s exit
01 Nov 2024 //
FIERCE BIOTECH
Positive Ph3 Results For UCB/Biogen`s Dapirolizumab Pegol
07 Oct 2024 //
PR NEWSWIRE
UCB Announces Two-Year Data For Bimzelx In Hidradenitis At EADV
27 Sep 2024 //
PR NEWSWIRE
UCB Presents 4-Year Bimzelx Data At EADV 2024
25 Sep 2024 //
PR NEWSWIRE
New Insights Highlight Unmet Needs In Lennox-Gastaut Syndrome
09 Sep 2024 //
PR NEWSWIRE
UCB Announces Strategic Divestment in China
28 Aug 2024 //
CONTRACT PHARMA
Drugmaker Mundipharma`s China unit sale fails to find buyer, sources say
28 Aug 2024 //
REUTERS
Belgium`s UCB to sell China neurology, allergy business for $680 mln
26 Aug 2024 //
REUTERS
FINTEPLA® (Fenfluramine) Results On Managing Seizures Published In Epilepsia
24 Jun 2024 //
PR NEWSWIRE
Ucb Bimzelx® Hs Phase 3 Published: The Lancet Hidradenitis Data Release
23 May 2024 //
PR NEWSWIRE
BIMZELX Phase 3 Showed Improvements in Skin Pain and Draining Tunnel Count
08 Mar 2024 //
PR NEWSWIRE
After busy 2023, UCB expects approval spree to keep rolling
29 Feb 2024 //
FIERCE PHARMA
UCB on Growth Path for a Decade Plus
28 Feb 2024 //
PR NEWSWIRE
FDA Issues Form 483 to UCB Farchim SA
24 Oct 2023 //
FDA
UCB presents late-breaking posters at Child Neurology Society Meeting
04 Oct 2023 //
PR NEWSWIRE
FDA reviews UCB psoriasis drug after manufacturing inspection
20 Sep 2023 //
FIERCE PHARMA
Lundbeck hires UCB neurology exec as new CEO
27 Jun 2023 //
FIERCE PHARMA
Ariceum and UCB to seek therapies for immune-related diseases and cancer
11 May 2023 //
PHARMACEUTICAL TECHNOLOGY
UCB touts new data for bimekizumab in hidradenitis suppurativa
20 Mar 2023 //
FIERCE PHARMA
UCB’s bimekizumab issued NICE recommendation for severe plaque psoriasis
02 Aug 2021 //
PHARMATIMES
UCB Demonstrates Commitment to Science Across Its Epilepsy Portfolio
04 Dec 2020 //
PRNEWSWIRE
Amgen, Takeda and UCB join forces in new COVID-19 drug repurposing study
02 Dec 2020 //
FIERCE PHARMA
UCB Flexes M&A Muscles to Bolster its Gene Therapy Capabilities
12 Nov 2020 //
BIOSPACE
UCB strengthens its gene therapy activities with additional pipeline programs
11 Nov 2020 //
PRNEWSWIRE
UCB is beefing up its gene therapy ops with back-to-back deals to buy a startup
11 Nov 2020 //
ENDPTS
UCB acquires gene therapy specialist Handl Therapeutics
11 Nov 2020 //
PHARMATIMES
UCB Announces New Data from its Epilepsy Portfolio on the AmericanNeurology
25 Jun 2020 //
PRNEWSWIRE
UCB Announces New Data from its Epilepsy Portfolio on the AMNV Platform
24 Jun 2020 //
PRNEWSWIRE
